Near Infrared Light (940nm) Improves COVID Outcomes: Exciting Randomized Control Trial
Roger Seheult, MD of MedCram examines an exciting randomized control trial demonstrating the effects of near infrared light on COVID-19.
January 3, 2023
Roger Seheult, MD of MedCram examines an exciting randomized control trial demonstrating the effects of near infrared light on COVID-19.
Photobiomodulation and methylene blue are neuroprotective. These interventions not only reduce cellular apoptosis, but also improve the tissue healing by improving the blood flow to the tissues. Let’s review how photobiomodulation works to help mitochondria heal and function correctly.
Huberman Lab describes the mechanisms by which different wavelengths of light impact the cells, tissues and organs of the human body, and how specifically timed light exposure of specific wavelengths can be used to improve sleep, enhance alertness, modulate hormone levels, and improve mood.
Low-level light therapy (LLLT) is a recent addition to the pantheon of light-based therapeutic interventions. The absorption of red/near-infrared light energy, a process termed “photobiomodulation,” enhances mitochondrial ATP production, cell signaling, and growth factor synthesis, and attenuates oxidative stress.
Michael Hamblin, PhD, Uni of Johannesburg @Synchrony2020
Patient Linda was diagnosed with stage 3 cancer. Her doctor told her that her neuropathy would worsen and won’t be able to walk again. She met with Leigh Erin Connealy, MD and she recommended that she see Martin Bales, LAc DAOM for her neuropathy. After a couple of Firefly treatments from Dr. Bales, she can feel her feet again.
To evaluate the hypothesis that light could reduce the lethality of COVID-19.
The purpose of this study was to compare the effects of laser photobiomodulation therapy (lPBMt) and ultrasound therapy (UST) in patients with chronic non-specific low back pain (CNLBP). Forty-five patients with CNLBP aged 30-40 years were divided randomly into three groups of 15 subjects each.
Next to cancer, Alzheimer’s disease (AD) and dementia is probably the most worrying health problem facing the Western world today. A large number of clinical trials have failed to show any benefit of the tested drugs in stabilizing or reversing the steady decline in cognitive function that is suffered by dementia patients.
Contrary to conventional wisdom, brain regeneration is possible. One promising therapy that promotes neurogenesis and is effective in pre-clinical studies of Alzheimer’s and Parkinson’s is near infrared light therapy, and it may improve other mental illnesses and neurodegenerative disorders including dementia, stroke, ALS, and traumatic brain injury as well.
